Therapies

What is Gene Therapy?

It is a technique that involves altering the genetic material of cells to treat or prevent disease. It aims to introduce a normal, functional gene to compensate for the defective, disease-causing gene.

How does Gene Therapy work?

It is a technique that involves altering the genetic material of cells to treat or prevent disease. It aims to introduce a normal, functional gene to compensate for the defective, disease-causing gene.

The different aspects of gene therapy are :-

  • It employs various approaches: replacing a mutated gene with a healthy copy, inactivating a mutated gene, and introducing a new gene.
  • Unlike traditional drugs, gene therapy targets the root genetic causes inside cells.

Target Cancers

Gene Therapy is primarily used to treat:

  1. Hematologic cancers: Such as leukemia, lymphoma, and multiple myeloma.
  2. Non-cancerous blood disorders: Aplastic anemia, sickle cell anemia, and thalassemia.
  3. Genetic disorders: Severe combined immunodeficiency (SCID) and certain metabolic disorders.
  4. Solid cancers:- Brain tumors, gynaecological malignancies and other solid malignancies

Gene Therapy Focused on Cancer

  1. Suicide gene therapy
  2. Angiogenesis targeting therapy
  3. Immunization gene therapy
  4. Targeting cancer associated fibroblasts
  5. Targeting tumor cells derives exosomes
  6. Genome editing
  7. miRNA targeted therapy
  8. Transcription factor decoys
  9. Oncogene silencing
  10. Tumor suppressor gene replacement

In cancer treatment, gene therapy has demonstrated potential in enhancing the effectiveness of immune therapies, targeting tumors more precisely, and improving patient survival rates.

Source: Gene Therapy for Cancer Treatment: Past, Present and Future - PMC

Gene therapy is typically recommended for patients with advanced cancers who have not responded to conventional treatments like chemotherapy or immunotherapy. A thorough medical evaluation is required to determine eligibility.

  • Immune response is stimulated, which can reduce the effectiveness of Gene Therapy.
  • Viruses used as vector for gene transfer may cause toxicity, immune response, and inflammatory reactions int the host.
  • Disorders caused by effects in multiple gene can’t be treated effectively using gene therapy.
  • They can carry a limited amount genetic material. Therefore, some genes may be too big to fit into viruses.
  • Random insertion can disrupt normal gene.
  • Gene therapy holds immense potential for revolutionizing healthcare by providing novel treatments for genetic disorders, personalized medicine, and targeted cancer therapies. However, it also comes with inherent risks and ethical challenges that must be carefully considered and managed.

Alternative options may include:

  • Other immunotherapies
  • Targeted therapies
  • Participation in additional clinical trials
  • Supportive care to manage symptoms and improve quality of life.
Insurance coverage varies by provider and plan. Patients are advised to consult with their healthcare provider and insurance company to understand coverage options and potential costs.

Have Questions?

Fill in the details below.

Share your details below, and we’ll reach out to you without delay.

Disclaimer : We will be using this information for calling purposes only.

Share your details below, and we’ll reach out to you without delay.

Disclaimer : We will be using this information for calling purposes only.

SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct head and neck cancer case study using TCR-p53 therapy in inoperable squamous cell carcinoma
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male